- The United States International Development Finance Corporation (DFC) primarily responsible for providing and facilitating the financing of private development projects in lower- and middle-income countries have announced a joint financing package of €600 million for Aspen Pharmacare Holdings Ltd, South Africa.
- The package is aimed at supporting Aspen’s efforts to produce COVID-19 vaccines
The United States International Development Finance Corporation (DFC) primarily responsible for providing and facilitating the financing of private development projects in lower- and middle-income countries have announced a joint financing package of €600 million for Aspen Pharmacare Holdings Ltd, South Africa. The package is aimed at supporting Aspen’s efforts to produce COVID-19 vaccines with Stringent Regulatory Authorization (SRA) and/or World Health Organization (WHO) Emergency Use Listing, including the Johnson & Johnson COVID-19 vaccine. The fundamental goal of the package is to scale up vaccine production, invest in African ingenuity and resilience, and help the global community beat this COVID-19 pandemic.
DEG (Germany), Proparco (France), and the International Finance Corporation (IFC) are also partnering with DFC to provide the financing support. The manufactured vaccines will be distributed to the African Union, South African Government, and COVAX.
